- 专利标题： NOVEL PYRIMIDINES AS EGFR-INHIBITORS AND METHODS OF TREATING DISORDERS
-
申请号： US18309164申请日： 2023-04-28
-
公开(公告)号： US20230348434A1公开(公告)日： 2023-11-02
- 发明人: Nathanael S. Gray , Pasi Janne , Hwan Geun Choi , Jaebong Jang
- 申请人： Dana-Farber Cancer Institute, Inc.
- 申请人地址： US MA Boston
- 专利权人： Dana-Farber Cancer Institute, Inc.
- 当前专利权人： Dana-Farber Cancer Institute, Inc.
- 当前专利权人地址： US MA Boston
- 分案原申请号： US16950465 2020.11.17
- 主分类号： C07D403/04
- IPC分类号： C07D403/04 ; C07D471/04 ; C07D403/14 ; C07D487/04
摘要：
The application relates to a compound having Formula (I):
which modulates the activity of EGFR, a pharmaceutical composition comprising the compound, and a method of treating or preventing a disease in which EGFR plays a role.
which modulates the activity of EGFR, a pharmaceutical composition comprising the compound, and a method of treating or preventing a disease in which EGFR plays a role.
信息查询
